1729
CONCLUSION : Losartan reduces the rate of progression of ADR - induced focal segmental glomerulosclerosis to end - stage renal disease in SHR .
 Chemical: Losartan; Chemical: ADR; Disease: focal segmental glomerulosclerosis; Disease: end - stage renal disease
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: Losartan; Chemical: ADR; Disease: focal segmental glomerulosclerosis; Disease: end - stage renal disease